Literature DB >> 24342023

Retinal blood vessel positional shifts and glaucoma progression.

Nathan M Radcliffe1, Scott D Smith2, Zeba A Syed3, Sung Chul Park4, Joshua R Ehrlich5, Carlos Gustavo De Moraes6, Jeffrey M Liebmann6, Robert Ritch7.   

Abstract

PURPOSE: To determine the characteristics and significance of retinal blood vessel (RBV) positional shifts over time in a cohort of patients with progressive glaucoma.
DESIGN: Retrospective cohort study. PARTICIPANTS: Baseline and serial stereophotographs from 1 eye of 125 patients with open-angle glaucoma with ≥8 reliable Swedish interactive threshold algorithm standard visual fields (VFs) were included. On the basis of global rates of threshold sensitivity change, patients with glaucoma were divided into groups of minimal (<-0.02 decibels [dB]/year), moderate (-0.02 to -0.65 dB/year), or fast (≥-0.65 dB/year) progression. To determine whether graders' assessments of RBV positional shifts were false-positives, a control group consisting of 33 patients with glaucoma with 2 sets of photographs taken on the same day was included.
METHODS: Masked graders reviewed serial photographs aligned with automated alternation flicker (EyeIC, Narbeth, PA) and assessed them for the presence of any discrete RBV positional shifts (2 graders) and for traditional measures of structural progression (2 graders), including neuroretinal rim loss, parapapillary atrophy progression, and disc hemorrhage (DH). MAIN OUTCOME MEASURES: Presence or absence of RBV positional shifts, rates of VF progression, and presence or absence of traditional measures of structural progression.
RESULTS: A total of 158 image sets (125 longitudinal and 33 same-day controls) from patients with glaucoma were included. Retinal blood vessel shifts were noted in 33 of 125 (26.4%) longitudinally followed glaucomatous eyes and 2 of 33 (6%) same-day control patients (P = 0.01). Agreement between graders I and II was 90.4% (kappa=0.77; P< 0.001). Eyes with RBV positional change progressed more rapidly than those without (-0.55 vs. -0.29 dB/year; 95% confidence interval [CI], 0.03-0.48); P = 0.03). Retinal blood vessel shift was present in 12.1% of minimal progressors versus 31.5% of moderate and fast progressors (P = 0.04). Rate of VF progression was statistically associated with RBV shift (odds ratio [OR], 2.2; 95% CI, 1.1-4.5; P = 0.03). Other variables significantly associated with RBV shift included neuroretinal rim loss (OR, 21.9; 95% CI, 5.7-83.6; P< 0.001) and DH (OR, 4.6; 95% CI, 1.5-15.5; P< 0.01). A multivariable model revealed that rim loss and DH, but not rate of functional change, were significantly associated with RBV shift.
CONCLUSIONS: Retinal blood vessel positional shifts occurred in eyes with functionally progressive glaucoma, neuroretinal rim loss, and DH. This is a novel clinical finding that could help identify glaucoma progression or individuals at higher risk for future progression.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24342023     DOI: 10.1016/j.ophtha.2013.11.002

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Relationship Between Central Retinal Vessel Trunk Location and Visual Field Loss in Glaucoma.

Authors:  Mengyu Wang; Hui Wang; Louis R Pasquale; Neda Baniasadi; Lucy Q Shen; Peter J Bex; Tobias Elze
Journal:  Am J Ophthalmol       Date:  2017-01-11       Impact factor: 5.258

2.  The impact of disc hemorrhage studies on our understanding of glaucoma: a systematic review 50 years after the rediscovery of disc hemorrhage.

Authors:  Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2018-11-21       Impact factor: 2.447

3.  Vessel Evaluation in Patients with Primary Open-Angle Glaucoma, Normal Tension Glaucoma and Healthy Controls.

Authors:  Constanze Kortuem; Johannes Dietter; Yagmur Bozkurt; Friederike Charlotte Kortuem; Annegret Abaza; Siegfried Wahl; Iliya V Ivanov; Marius Ueffing; Bogomil Voykov
Journal:  Clin Ophthalmol       Date:  2021-10-21

4.  Comparing Glaucomatous Disc Change Using Stereo Disc Viewing and the MatchedFlicker Software Program in Ophthalmologists-in-Training.

Authors:  Jamie L Schaefer; Zachary L Lukowski; Alissa M Meyer; Anthony J Leoncavallo; Anthony Greer; Gina M Martorana; Baiming Zou; Jonathan J Shuster; Mark B Sherwood
Journal:  Am J Ophthalmol       Date:  2016-03-31       Impact factor: 5.258

5.  Association of Optic Nerve Head Prelaminar Schisis With Glaucoma.

Authors:  Eugene A Lowry; Steven L Mansberger; Stuart K Gardiner; Hongli Yang; Facundo Sanchez; Juan Reynaud; Shaban Demirel; Claude F Burgoyne; Brad Fortune
Journal:  Am J Ophthalmol       Date:  2020-11-06       Impact factor: 5.258

6.  Defects Along Blood Vessels in Glaucoma Suspects and Patients.

Authors:  Donald C Hood; Nicole De Cuir; Maria A Mavrommatis; Daiyan Xin; Hassan Muhammad; Juan Reynaud; Robert Ritch; Brad Fortune
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04       Impact factor: 4.799

7.  The Interrelationship between Refractive Error, Blood Vessel Anatomy, and Glaucomatous Visual Field Loss.

Authors:  Mengyu Wang; Qingying Jin; Hui Wang; Dian Li; Neda Baniasadi; Tobias Elze
Journal:  Transl Vis Sci Technol       Date:  2018-01-18       Impact factor: 3.283

8.  Optic Disc Image Subtraction as an Aid to Detect Glaucoma Progression.

Authors:  Navid Amini; Reza Alizadeh; Nucharee Parivisutt; EunAh Kim; Kouros Nouri-Mahdavi; Joseph Caprioli
Journal:  Transl Vis Sci Technol       Date:  2017-10-27       Impact factor: 3.283

9.  Change of Retinal Vessels in Different Sectors of the Parapapillary Area in Primary Open-Angle Glaucoma.

Authors:  Jingyi Cheng; Hongmei Zhao; Chunhui Jiang; Xiangmei Kong; Xinghuai Sun
Journal:  Front Med (Lausanne)       Date:  2021-07-08

10.  Associations between Optic Nerve Head-Related Anatomical Parameters and Refractive Error over the Full Range of Glaucoma Severity.

Authors:  Neda Baniasadi; Mengyu Wang; Hui Wang; Mufeed Mahd; Tobias Elze
Journal:  Transl Vis Sci Technol       Date:  2017-07-18       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.